Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Harvard Business School
McKesson
McKinsey
Medtronic

Last Updated: June 29, 2022

PEPCID AC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Pepcid Ac patents expire, and what generic alternatives are available?

Pepcid Ac is a drug marketed by J And J Consumer Inc and is included in three NDAs. There is one patent protecting this drug.

The generic ingredient in PEPCID AC is famotidine. There are eighteen drug master file entries for this compound. Ninety-eight suppliers are listed for this compound. Additional details are available on the famotidine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pepcid Ac

A generic version of PEPCID AC was approved as famotidine by ATHENEX INC on April 16th, 2001.

  Try it Free

Summary for PEPCID AC
Drug patent expirations by year for PEPCID AC
Recent Clinical Trials for PEPCID AC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ohio State University Comprehensive Cancer CenterPhase 2/Phase 3
United States Department of DefensePhase 2
Leidos Life SciencesPhase 2

See all PEPCID AC clinical trials

Pharmacology for PEPCID AC

US Patents and Regulatory Information for PEPCID AC

PEPCID AC is protected by one US patents.

Patents protecting PEPCID AC

Process for preparing a soft tablet
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-001 Sep 24, 1998 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-002 Dec 17, 2007 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 OTC Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PEPCID AC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-001 Sep 24, 1998 See Plans and Pricing See Plans and Pricing
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 See Plans and Pricing See Plans and Pricing
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-002 Dec 17, 2007 See Plans and Pricing See Plans and Pricing
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-001 Sep 24, 1998 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PEPCID AC

See the table below for patents covering PEPCID AC around the world.

Country Patent Number Title Estimated Expiration
South Africa 9101293 See Plans and Pricing
Canada 2036707 MEDICAMENTS ENROBES ET APPAREILS ET METHODES POUR LA PREPARATION DESDITS MEDICAMENTS (IMPROVED COATED MEDICAMENTS AND APPARATUS AND METHODS FOR MAKING THE SAME) See Plans and Pricing
Australia 7131491 See Plans and Pricing
Spain 8100281 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Harvard Business School
Mallinckrodt
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.